Home > Insider Trading > Filing (0000899243-20-000387)

Filing Details

Accession Number:: 0000899243-20-000387
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-01-03 20:18:43
Reporting Period:: 2020-01-01

Accepted Time:: 2020-01-03 20:18:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1552451	Myokardia Inc	MYOK	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413822	Anastasios Gianakakos	C/O Myokardia Inc. 333 Allerton Avenue South San Francisco CA 94080	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-01-01	27,950	$0.00	114,464	No	4	M	Direct
Common Stock	Disposition	2020-01-03	300	$70.35	114,164	No	4	S	Direct
Common Stock	Disposition	2020-01-03	2,616	$71.59	111,548	No	4	S	Direct
Common Stock	Disposition	2020-01-03	2,084	$72.27	109,464	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2020-01-01	7,650	$0.00	7,650	$0.00
Common Stock	Restricted Stock Units	Disposition	2020-01-01	20,300	$0.00	20,300	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,300			No	4	M	Direct
60,900			No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	225,947	Indirect	By Reporting Person's Trust 2
Common Stock	323,526	Indirect	By Reporting Person's Trust 3
Common Stock	12,200	Indirect	By Trust 1
Common Stock	12,200	Indirect	By Trust 2
Common Stock	12,200	Indirect	By Trust 3

Footnotes

Restricted stock units convert into common stock on a one-for-one basis.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer.
Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents the weighted average sale price of the shares sold ranging from $69.93 to $70.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average sale price of the shares sold ranging from $70.99 to $71.98 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average sale price of the shares sold ranging from $72.03 to $72.73 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.